Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report

• Egile Nagusiak: Shintaro Sakai (Egilea), Yoshiro Morimoto (Egilea), Yusuke Matsuzaka (Egilea), Takeshi Nakano (Egilea), Shinji Kanegae (Egilea), Akira Imamura (Egilea), Hiroki Ozawa (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2021-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Tardive dyskinesia (TD) is a common side effect of antipsychotics, and it remains a persistent and challenging problem. The blonanserin transdermal patch, developed in Japan and launched in September 2019, is the first antipsychotic transdermal treatment. Here, we describe a patient with sc...